Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2005 1
2006 2
2007 4
2008 3
2009 6
2010 8
2011 7
2012 5
2013 4
2014 5
2015 4
2016 6
2017 6
2018 6
2019 10
2020 12
2021 5
2022 6
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Pre-B acute lymphoblastic leukemia presenting with NPM1 and FLT3 mutations.
Khan AA, James D, Andresen V, Atkey J, Bradbury R, Cargo C, Dillon R, Gjertsen BT, Goldstone AR, Leach R, Lock D, Narayanan M, Russell N, Verigou EA, Green S, Fielding AK, Falini B. Khan AA, et al. Among authors: fielding ak. Am J Hematol. 2024 Apr 3. doi: 10.1002/ajh.27301. Online ahead of print. Am J Hematol. 2024. PMID: 38567798 No abstract available.
Management of ALL in Adults: 2023 ELN Recommendations from a European Expert Panel.
Gökbuget N, Boissel N, Chiaretti S, Dombret H, Doubek M, Fielding AK, Foà R, Giebel S, Hoelzer D, Hunault M, Marks DI, Martinelli G, Ottmann O, Rijneveld AW, Rousselot P, Ribera JM, Bassan R. Gökbuget N, et al. Among authors: fielding ak. Blood. 2024 Feb 2:blood.2023023568. doi: 10.1182/blood.2023023568. Online ahead of print. Blood. 2024. PMID: 38306595
Diagnosis, Prognostic Factors and Assessment of ALL in Adults: 2023 ELN Recommendations from a European Expert Panel.
Gökbuget N, Boissel N, Chiaretti S, Dombret H, Doubek M, Fielding AK, Foà R, Giebel S, Hoelzer D, Hunault M, Marks DI, Martinelli G, Ottmann OG, Rijneveld AW, Rousselot P, Ribera JM, Bassan R. Gökbuget N, et al. Among authors: fielding ak. Blood. 2024 Jan 31:blood.2023020794. doi: 10.1182/blood.2023020794. Online ahead of print. Blood. 2024. PMID: 38295337
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study.
Enshaei A, Joy M, Butler E, Kirkwood AA, Messina M, Pavoni C, Morgades M, Harrison CJ, Foà R, Ribera JM, Chiaretti S, Bassan R, Fielding AK, Moorman AV. Enshaei A, et al. Among authors: fielding ak. Blood Adv. 2024 Mar 12;8(5):1155-1166. doi: 10.1182/bloodadvances.2023011661. Blood Adv. 2024. PMID: 38113467 Free PMC article.
Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platform.
Enshaei A, Martinez Elicegui J, Anguiano E, Gibson J, Lawal S, Ampatzidou M, Doubek M, Fielding AK, La Sala E, Middleton E, Rijneveld AW, Turki AT, Zimmermann M, Vora A, Moorman AV. Enshaei A, et al. Among authors: fielding ak. Leukemia. 2023 Dec;37(12):2493-2496. doi: 10.1038/s41375-023-02046-0. Epub 2023 Sep 29. Leukemia. 2023. PMID: 37773265 Free PMC article. No abstract available.
ALL-RIC trial protocol: a comparison of reduced dose total body irradiation (TBI) and cyclophosphamide with fludarabine and melphalan reduced intensity conditioning in adults with acute lymphoblastic leukaemia (ALL) in complete remission.
Marks DI, Castleton A, Olavarria E, Gilleece M, Fielding A, Mikhaeel G, Beasley M, Diez P, Jackson A, Hodgkinson A, Elhanied M, Chakraverty R. Marks DI, et al. Among authors: fielding a. BMJ Open. 2023 Jun 1;13(6):e067790. doi: 10.1136/bmjopen-2022-067790. BMJ Open. 2023. PMID: 37263700 Free PMC article.
Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia.
Leongamornlert D, Gutiérrez-Abril J, Lee S, Barretta E, Creasey T, Gundem G, Levine MF, Arango-Ossa JE, Liosis K, Medina-Martinez JS, Zuborne Alapi K, Kirkwood AA, Clifton-Hadley L, Patrick P, Jones D, O'Neill L, Butler AP, Harrison CJ, Campbell P, Patel B, Moorman AV, Fielding AK, Papaemmanuil E. Leongamornlert D, et al. Among authors: fielding ak. Blood Adv. 2023 Aug 8;7(15):3862-3873. doi: 10.1182/bloodadvances.2022008992. Blood Adv. 2023. PMID: 36867579 Free PMC article.
A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care.
El-Galaly TC, Gaidzik VI, Gaman MA, Antic D, Okosun J, Copland M, Sexl V, Fielding AK, Doeswijk R, Parker H, Dreyling M, Döhner K, Almeida AM, Macintyre E, Gribben JG, Grønbæk K. El-Galaly TC, et al. Among authors: fielding ak. Hemasphere. 2023 Feb 21;7(3):e842. doi: 10.1097/HS9.0000000000000842. eCollection 2023 Mar. Hemasphere. 2023. PMID: 36844176 Free PMC article. No abstract available.
Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies.
Khan AO, Rodriguez-Romera A, Reyat JS, Olijnik AA, Colombo M, Wang G, Wen WX, Sousos N, Murphy LC, Grygielska B, Perrella G, Mahony CB, Ling RE, Elliott NE, Karali CS, Stone AP, Kemble S, Cutler EA, Fielding AK, Croft AP, Bassett D, Poologasundarampillai G, Roy A, Gooding S, Rayes J, Machlus KR, Psaila B. Khan AO, et al. Among authors: fielding ak. Cancer Discov. 2023 Feb 6;13(2):364-385. doi: 10.1158/2159-8290.CD-22-0199. Cancer Discov. 2023. PMID: 36351055 Free PMC article.
98 results